Papers associated with whole organism (and pou2f1)

Limit to papers also referencing gene:
Show all whole organism papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	In vitro modeling of cranial placode differentiation: Recent advances, challenges, and perspectives., Griffin C., Dev Biol. February 1, 2024; 506 20-30.
	High-throughput analysis reveals novel maternal germline RNAs crucial for primordial germ cell preservation and proper migration., Owens DA., Development. January 15, 2017; 144 (2): 292-304.
	Retention of duplicated ITAM-containing transmembrane signaling subunits in the tetraploid amphibian species Xenopus laevis., Guselnikov SV., Dev Comp Immunol. November 1, 2015; 53 (1): 158-68.
	Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3., Sala-Rabanal M., Mol Pharm. April 1, 2013; 10 (4): 1450-8.
	Transcription factors involved in lens development from the preplacodal ectoderm., Ogino H., Dev Biol. March 15, 2012; 363 (2): 333-47.
	Dynamic regulation of Oct1 during mitosis by phosphorylation and ubiquitination., Kang J., PLoS One. January 1, 2011; 6 (8): e23872.
	Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter., Astrand C., Exp Cell Res. September 10, 2009; 315 (15): 2604-15.
	A microarray screen for direct targets of Zic1 identifies an aquaporin gene, aqp-3b, expressed in the neural folds., Cornish EJ., Dev Dyn. May 1, 2009; 238 (5): 1179-94.
	The POU homeobox protein Oct-1 regulates radial glia formation downstream of Notch signaling., Kiyota T., Dev Biol. March 15, 2008; 315 (2): 579-92.
	Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps., Ballestero MR., Biochem Pharmacol. September 14, 2006; 72 (6): 729-38.
	Comparative genomics on SOX2 orthologs., Katoh Y., Oncol Rep. September 1, 2005; 14 (3): 797-800.
	A consensus Oct1 binding site is required for the activity of the Xenopus Cdx4 promoter., Reece-Hoyes JS., Dev Biol. June 15, 2005; 282 (2): 509-23.
	Nuclear factor 1 and octamer transcription factor 1 binding preset the chromatin structure of the mouse mammary tumor virus promoter for hormone induction., Belikov S., J Biol Chem. November 26, 2004; 279 (48): 49857-67.
	Chromatin-mediated restriction of nuclear factor 1/CTF binding in a repressed and hormone-activated promoter in vivo., Belikov S., Mol Cell Biol. April 1, 2004; 24 (7): 3036-47.
	Renal organic cation and nucleoside transport., Chen R., Biochem Pharmacol. July 15, 2002; 64 (2): 185-90.
	Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct., Pavlova A., Am J Physiol Renal Physiol. April 1, 2000; 278 (4): F635-43.
	Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain., Kusuhara H., J Biol Chem. May 7, 1999; 274 (19): 13675-80.
	Non-cell autonomous induction of apoptosis and loss of posterior structures by activation domain-specific interactions of Oct-1 in the Xenopus embryo., Veenstra GJ., Cell Death Differ. September 1, 1998; 5 (9): 774-84.
	Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta., Kekuda R., J Biol Chem. June 26, 1998; 273 (26): 15971-9.
	Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney., Lopez-Nieto CE., J Biol Chem. March 7, 1997; 272 (10): 6471-8.
	cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2., Okuda M., Biochem Biophys Res Commun. July 16, 1996; 224 (2): 500-7.
	Dynamic and differential Oct-1 expression during early Xenopus embryogenesis: persistence of Oct-1 protein following down-regulation of the RNA., Veenstra GJ., Mech Dev. April 1, 1995; 50 (2-3): 103-17.
	Distinct elements of the xsna promoter are required for mesodermal and ectodermal expression., Mayor R., Development. November 1, 1993; 119 (3): 661-71.
	The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity., Hentsch B., Nucleic Acids Res. June 11, 1992; 20 (11): 2657-65.
	Sequential expression of multiple POU proteins during amphibian early development., Hinkley CS., Mol Cell Biol. February 1, 1992; 12 (2): 638-49.

???pagination.result.page??? 1